Eisai
4523.T
#1920
Rank
A$12.94 B
Marketcap
$45.93
Share price
-0.56%
Change (1 day)
-41.45%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2023 (TTM): $3.26

According to Eisai's latest financial reports the company's current EPS (TTM) is $3.35. In 2022 the company made an earnings per share (EPS) of $2.46 a decrease over its 2021 EPS that were of $10.92.

EPS history for Eisai from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$3.2632.47%
2022$2.46-77.48%
2021$10.92-41.88%
2020$18.79-0.94%
2019$18.9752.59%
2018$12.43124.17%
2017$5.55-49.42%
2016$10.9737.08%
2015$8.00-11.75%
2014$9.06-3.23%
2013$9.37-18.56%
2012$11.50-15.51%
2011$13.61-3.75%
2010$14.15-1.36%
2009$14.34